GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » Equity-to-Asset

iZafe Group AB (OSTO:IZAFE B) Equity-to-Asset : 0.68 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. iZafe Group AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr19.83 Mil. iZafe Group AB's Total Assets for the quarter that ended in Mar. 2024 was kr29.40 Mil. Therefore, iZafe Group AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.68.

The historical rank and industry rank for iZafe Group AB's Equity-to-Asset or its related term are showing as below:

OSTO:IZAFE B' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.2   Med: 0.68   Max: 0.87
Current: 0.68

During the past 13 years, the highest Equity to Asset Ratio of iZafe Group AB was 0.87. The lowest was 0.20. And the median was 0.68.

OSTO:IZAFE B's Equity-to-Asset is ranked better than
56% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs OSTO:IZAFE B: 0.68

iZafe Group AB Equity-to-Asset Historical Data

The historical data trend for iZafe Group AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB Equity-to-Asset Chart

iZafe Group AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.84 0.84 0.77 0.73

iZafe Group AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.82 0.83 0.73 0.68

Competitive Comparison of iZafe Group AB's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, iZafe Group AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iZafe Group AB's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's Equity-to-Asset falls into.



iZafe Group AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

iZafe Group AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=25.353/34.614
=0.73

iZafe Group AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=19.832/29.399
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iZafe Group AB  (OSTO:IZAFE B) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


iZafe Group AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


iZafe Group AB (OSTO:IZAFE B) Business Description

Traded in Other Exchanges
N/A
Address
Grev Turegatan 11A, Stockholm, SWE, 114 46
iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB (OSTO:IZAFE B) Headlines

No Headlines